Duncan Charles Cliff
Vanda Pharmaceuticals Inc. · Director
Duncan Charles Cliff is listed in filings as Director at Vanda Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including 2 public disclosures. Recent filings connect the profile to Vanda Pharmaceuticals Inc. (VNDA). The current snapshot covers public activity from Apr 24, 2026 to Jun 8, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||